ABOUT GIPO

The GM-CSF Inhalation Promoting Organization (GIPO) is an organization working to overcome intractable respiratory diseases, such as pulmonary alveolar proteinosis, and improve the quality of life of patients. The organization is comprised mainly of doctors who have conducted clinical trials on GM-CSF inhalation therapy over many years and established clinical guidelines and treatment protocols.

We actively disseminate information in cooperation with related organizations so that the diagnosis and treatment of pulmonary alveolar proteinosis, for which GM-CSF inhalation therapy is now covered by the general health insurance system in Japan, can be received at any medical institution nationwide. We will contribute to the early diagnosis of pulmonary alveolar proteinosis, appropriate treatment, and improvement of patients' quality of life. We also promote research to expand new applications of GM-CSF inhalation therapy.